First of all, kudos for actually posting a specific study, and not a link to “c19ivm.org.” Unfortunately however, like nearly all of the studies on that often-shared site, this one isn’t very good. It’s an observational study, not randomized, and didn’t really have “88,012 subjects.” When they trimmed the numbers down (probably to get rid of results they didn’t like), they were only left with 283 “regular users” of ivermectin. It also wasn’t randomized, and the results can be explained by things other than the treatments: https://www.medrxiv.org/content/10.1101/2023.08.10.23293924v1
Oh and the authors were funded by an ivermectin manufacturer…